Abstract CT115: Updated survival results of the KEYNOTE-040 study of pembrolizumab vs standard-of-care chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Abstract CT115: Updated survival results of the KEYNOTE-040 study of pembrolizumab vs standard-of-care chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma

Published:2018-07-01 Issue: Volume: Page:
ISSN:
Container-title:Clinical Trials
language:
Short-container-title:

Author:

Soulieres Denis,Cohen Ezra,Tourneau Christophe Le,Dinis Jose,Licitra Lisa,Ahn Myung-Ju,Soria Ainara,Machiels Jean-Pascal,Mach Nicolas,Mehra Ranee,Burtness Barbara,Zhang Pingye,Cheng Jonathan,Swaby Ramona,Harrington Kevin J.

Publisher

American Association for Cancer Research

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CO-DELIVERY of glutamic acid-extended peptide antigen and imidazoquinoline TLR7/8 agonist via ionizable lipid nanoparticles induces protective anti-tumor immunity;Biomaterials;2024-12

2. Modulation of PD‑L1 expression by standard therapy in head and neck cancer cell lines and exosomes;International Journal of Oncology;2023-07-27

3. Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas;Journal of Clinical Medicine;2022-12-07

4. Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review);International Journal of Oncology;2022-06-01

5. Immunotherapy for head and neck cancer: Present and future;Critical Reviews in Oncology/Hematology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP